Dataset Information

Using C-reactive protein (CRP) for earlier detection of Infectious complications following Colorectal Surgery

ABSTRACT: Interventions: Prospective, non-randomised, non-blinded clinical trial comparing two patient groups over two consecutive time periods. Group 1 (Standard Care) – Patients have CRP levels measured on postoperative days 3 to 5 via a simple peripheral venous blood test which will be collected by a phlebotomist or doctor from the surgical team. A septic screen is performed based on the patients clinical status (vital signs, examination findings) rather than CRP alone. Group 2 (CRP protocol group) - Patients have CRP levels measured on postoperative days 3 to 5 as for Group 1. If the CRP value is above certain thresholds on these days (>170mg/L on day 3, >125mg/L on day 4, or >50mg/L increase between day 3 and 4, or between day 4 and 5), a ‘septic screen’ will be performed on the same day to look for a source of infection regardless of normal vital signs or examination findings. This will include: - CT scan of the abdomen and pelvis - Chest x-ray - Cultures of urine, wound and blood/central lines Fidelity of this data will be ensured through prospective collection of CRP data and complications and further assessed through audit of electronic records and hospital notes at the end of the study. Primary outcome(s): Infectious complications (e.g. wound infection, chest infection, urinary tract infection, anastomotic leak, abdominal collection). These will be assessed by the surgical team as part of routine clinical care and postoperative follow-up. They will be prospectively recorded by the principal investigator and research team.[Assessed daily while in hospital and then weekly once discharged until 30 days post surgery.] Study Design: Purpose: Diagnosis; Allocation: Non-randomised trial

DISEASE(S): Surgery-other Surgery,Colorectal Cancer,Oral And Gastrointestinal-inflammatory Bowel Disease,Diverticular Disease,Cancer-bowel-back Passage (rectum) Or Large Bowel (colon),Inflammatory Bowel Disease

PROVIDER: 2469773 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

ACCESS DATA

Similar Datasets

Project description:The salmon louse is an ectoparasitic copepod that causes major economic losses in the aquaculture industry of Atlantic salmon. This host displays a high level of susceptibility to lice which can be accounted for by several factors including stress. In addition, the parasite itself acts as a potent stressor of the host, and outcomes of infection can depend on biotic and abiotic factors that stimulate production of cortisol. Consequently, examination of responses to infection with this parasite, in addition to stress hormone regulation in Atlantic salmon, is vital for better understanding of the host pathogen interaction. Atlantic salmon post smolts were exposed to stress hormone cortisol, lice and their combination. The transcriptomic effects of hormone treatment in salmon skin were significantly greater than lice-infection induced changes. Cortisol stimulated expression of genes involved in metabolism of steroids and amino acids, chaperones, responses to oxidative stress and eicosanoid metabolism and suppressed genes related to antigen presentation, B and T cells, antiviral and inflammatory responses. Cortisol and liceBoth treatments equally down-regulated a large panel of motor proteins that can be important for wound contraction. Cortisol also suppressed multiple genes involved in wound healing, parts of which were activated by the parasite. Down-regulation of collagens and other structural proteins was in parallel with the induction of proteinases that degrade extracellular matrix (MMP9 and MMP13). Cortisol reduced expression of genes encoding proteins involved in formation of various tissue structures, regulators of cell differentiation and growth factors. Atlantic salmon post smolts were organised into four experimental groups: lice + cortisol, lice + placebo, no lice + cortisol, no lice + placebo. Infection levels were equal in both treatments upon termination of the experiment. Gene expression changes in skin were assessed with 21 k oligonucleotide microarray and qPCR at the chalimus stage 18 days post infection at 9oC.

Dataset Information

Using C-reactive protein (CRP) for earlier detection of Infectious complications following Colorectal Surgery

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure